Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03221374 · ClinicalTrials.gov registry record · NA
Mind-body Awareness Training and Brain-computer Interface
A NA study, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT03221374: Completed NA study, sponsored by Carnegie Mellon University.
NCT03221374 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 231 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03221374, a NA study, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
Mind-Body Awareness Training (MBAT), in the forms of various yoga and meditative practices, has become increasingly prevalent due to an increase in awareness of the potential health benefits, and improvements in concentration that this training can provide to practitioners. In the present study, the role of Mind-Body Awareness Training (MBAT) in the initial learning of a sensorimotor (SMR) based Brain-Computer Interface (BCI) is being investigated. The hypothesis is that MBAT will improve performance in SMR based BCI.
Primary Outcome
This outcome is related to the sub-study to investigate the effect of the MBSR on BCI learning. During the course of the sub-study over approximately 6 months/cohort of participants, participant learning over time during the course of study will be examined in terms of performance change after the intervention as well as across sessions, with a positive number representing an increase, and a negative number to represent a decrease. The percent valid correct (percent correct over valid trials) me
Interventions
- BEHAVIORAL Mindfulness Based Stress Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT03221374 record still lists
NCT03221374 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Stress Reduction is the first listed.
NCT03221374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03221374 about?
NCT03221374 is a clinical study titled "Mind-body Awareness Training and Brain-computer Interface". Mind-Body Awareness Training (MBAT), in the forms of various yoga and meditative practices, has become increasingly prevalent due to an increase in awareness of the potential health benefits, and improvements in concentration that this training can provide to practitioners. In the present study, the...
What is the current status of trial NCT03221374?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2016-09-01. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03221374?
The interventions under investigation include: Mindfulness Based Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT03221374?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03221374's enrollment target sits among peer trials
231 465th of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI